Objectifying the body positive movement: The effects of sexualizing and digitally modifying body-positive images on Instagram.

The body positive movement on social media seeks to challenge narrow conceptualizations of beauty that media outlets traditionally perpetuate and reinforce. Through a 2 × 2 between-subjects online experiment, we examined how the nature and authenticity of body-positive imagery on social media affects female viewers and their evaluations of body-positive content (N = 425, Mage = 35.47, SDage = 13.52). Specifically, participants viewed and reacted to a series of 10 body-positive images of women on social media varying in their degree of sexualization (sexualized vs. non-sexualized) and evidence of digital photo modifications (modification icons vs. no modification icons). A control group that featured landscape images was also included. Results indicate body-positive images that are considered sexualized and are believed to be digitally modified can undercut the movement's intended aims: Participants who viewed body-positive images that were sexualized (vs. non-sexualized) and included photo modification icons (vs. no modification icons) reported greater endorsement of traditional beauty ideals (e.g., thinness) and thought the images were shared for self-serving reasons (e.g., to gain likes/shares/endorsements); these relationships were mediated by the extent to which viewers believed these images were sexualized and digitally modified. Further, results indicate that sexualized body-positive images can instigate sexual objectification of others and oneself. Those who viewed control images (vs. experimental body-positive images) produced significantly fewer sexually objectifying words about others and themselves. Implications for both viewers and producers (e.g., individuals, corporations) of body-positive imagery on social media are discussed in light of objectification theory.

The effects of engaging in digital photo modifications and receiving favorable comments on women's selfies shared on social media.

The present study explores how the construction and distribution of selfies might interact with features of newer media to affect women who share selfies on social media. In particular, this study focuses on how specific types of photo modification and the nature of favorable audience feedback received on one's images might exert influence on women's state self-objectification and body image concerns. A 3 × 2 between-subjects lab experiment was conducted to explore how the type of photo modification (appearance modifications, nonappearance modifications, or no modifications [control]) and nature of positive feedback (appearance comments vs. nonappearance comments) affect state self-objectification, state appearance satisfaction, pro-cosmetic surgery attitudes, and willingness to distribute selfies on social media in the future. Results indicate that modifying selfies leads to less appearance satisfaction and lower pro-cosmetic surgery attitudes. Receiving appearance comments on selfies heightens state self-objectification, regardless of the type of photo modification. In addition, the more women self-objectified, the more inclined they were to share similarly objectifying selfies on social media in the future. The findings of this work provide a more comprehensive understanding of how women are impacted by the images they share online.

The effects of viewing thin, sexualized selfies on Instagram: Investigating the role of image source and awareness of photo editing practices.

This experiment examined how features of images shared on social media sites, such as Instagram, impact and are evaluated by young adult female users. Specifically, we examined conditions under which female viewers (N = 360, Mage = 20.34, SD = 2.74) were more or less likely to internalize the thin ideal after viewing other women's selfies (i.e., images taken of oneself by oneself) posted on Instagram that depicted the thin ideal. We also examined how female viewers evaluated women who posted these selfies. Results indicated that the more female viewers believed that the women digitally modified or altered their selfies, the less likely viewers were to internalize the thin ideal. In addition, the more female viewers believed the women digitally modified their selfies and the more they believed the women were their offline peers (vs. models), the more negatively (e.g., less intelligent, less honest) they evaluated the women. Explanations for why awareness of photo modification and different image sources (peers vs. models) influence evaluations of selfies are discussed.

Latinos' Access to Online and Formal Mental Health Support.

Research on mental health services disparities affecting minority populations of the USA tends to neglect online mental health support (OMHS). The main objective of this study was to investigate online mental health support and help-seeking of Latino citizens living in US communities by estimating associations linking OMHS with a selection of individual and community variables. In addition, the extent to which unmet mental health treatment needs among adults are associated with key variables was examined. Variables of interest included economic resources, health insurance and coverage, confidentiality, perceived stigma, and accessibility. Data are from 39,630 Latino adult participants in the National Surveys on Drug Use and Health (NSDUH), 2004-2010. Results indicate that for every 10,000 US Latino adults, fewer than 25 individuals received recent OMHS, as compared to a recently published estimate of 270-330 per 10,000 for the US population generally. Among Latinos with self-described unmet mental health needs, an estimated 40% identified cost of treatment as a prominent barrier that explained why they had not received formal mental health treatment services. Research and policy health disparities implications are discussed.

Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.

BACKGROUND: Many concerns have been raised about pharmaceutical companies marketing their drugs directly to consumers on social media. This form of direct-to-consumer advertising (DTCA) can be interactive and, because it is largely unmonitored, the benefits of pharmaceutical treatment could easily be overemphasized compared to the risks. Additionally, nonexpert consumers can share their own drug product testimonials on social media and illegal online pharmacies can market their services on popular social media sites. There is great potential for the public to be exposed to misleading or dangerous information about pharmaceutical drugs on social media. OBJECTIVE: Our central aim was to examine how pharmaceutical companies use social media to interact with the general public and market their drugs. We also sought to analyze the nature of information that appears in search results for widely used pharmaceutical drugs in the United States on Facebook, Twitter, and YouTube with a particular emphasis on the presence of illegal pharmacies. METHODS: Content analyses were performed on (1) social media content on the Facebook, Twitter, and YouTube accounts of the top 15 pharmaceutical companies in the world and (2) the content that appears when searching on Facebook, Twitter, and YouTube for the top 20 pharmaceutical drugs purchased in the United States. Notably, for the company-specific analysis, we examined the presence of information similar to various forms of DTCA, the audience reach of company postings, and the quantity and quality of company-consumer interaction. For the drug-specific analysis, we documented the presence of illegal pharmacies, personal testimonials, and drug efficacy claims. RESULTS: From the company-specific analysis, we found information similar to help-seeking DTCA in 40.7% (301/740) of pharmaceutical companies' social media posts. Drug product claims were present in only 1.6% (12/740) of posts. Overall, there was a substantial amount of consumers who interacted with pharmaceutical companies through commenting (23.9%, 177/740). For the drug-specific analysis, we found that the majority of search results contained drug product claims (69.4%, 482/695); more claims mentioned only benefits (44.8%, 216/482) relative to only risks (27.2%, 131/482). Additionally, approximately 25% (150/603) of posts on Twitter and YouTube were presented as personal testimonials. A considerable percentage of content on Facebook contained advertisements for illegal online pharmacies (17%, 16/92). CONCLUSIONS: Pharmaceutical companies avoid making drug product claims on their social media accounts but frequently post content that is consistent with FDA definitions for help-seeking DTCA. Thousands of people often view content posted by pharmaceutical companies on social media; users also share company postings making both direct and indirect influence possible. Finally, people are likely to be exposed to drug product claims and information about illegal pharmacies when searching for information about popular pharmaceutical drugs on social media.

Testing the proclaimed affordances of online support groups in a nationally representative sample of adults seeking mental health assistance.

In this study, explanations for why people turn to the Internet for social support are tested using a nationally representative sample of adults who sought mental health support through a traditional treatment outlet, an in-person support group, or an online support group. Results indicate that the more adults report having social stigma concerns, the more likely they are to seek support online instead of help from an in-person support group or traditional treatment. Likewise, as the reported number of logistical barriers to mental health treatment increases, a corresponding increase occurs in the odds of adults seeking online support instead of traditional treatment. These findings as well as estimates of demographic variation in the use of online support are discussed.

Toward primary prevention of extra-medical OxyContin® use among young people.

OBJECTIVE: The prevention research context includes current epidemic levels of hazards associated with extra-medical use of OxyContin® (to get high or otherwise outside prescribed boundaries) among teenagers and young adults, and a recent OxyContin® re-formulation with an intent to reduce these hazards, plus hope for possibly beneficial primary prevention impact. The aim is to create a benchmark of risk estimates for the years just prior to OxyContin® re-formulation in anticipation of potential public health benefit in future years, with a focus on teens and the youngest adults in the United States, and to compare two methods for estimating peak risk. METHOD: The data are from nationally representative probability sample surveys of 12-21 year olds, yielding estimates for incidence of extra-medical OxyContin® use. Samples are of the non-institutionalized United States population, recruited and assessed in National Surveys on Drug Use and Health (NSDUH), each year from 2004 through 2008. In aggregate, the sample includes 135,552 young people who had not used OxyContin® extra-medically prior to their year of survey assessment. RESULTS: The main outcome was the estimated population-level age-specific incidence of extra-medical OxyContin® use, 2004-2008. We found that during the 2004-2008 interval the estimated risk accelerated from age 12 years, reached a peak value in mid-adolescence at roughly five newly incident users per 1000 persons per year (95% confidence intervals, 0.3%, 0.7%), and then declined. A meta-analysis approach to year-by-year data differentiated age patterns more clearly than a pooled estimation approach. CONCLUSION: Studying young people in the United States, we have discovered that the risk of starting to use OxyContin® extra-medically rises to a peak by mid-adolescence and then declines. From a methods standpoint, the meta-analysis serves well in this context; there is no advantage to pooling survey data across years. We also discovered that during any given year a pediatrician might rarely see even one patient who has just started to use OxyContin® to get high or for other extra-medical purposes. Implications for screening are discussed.